SUBSCRIBE
SUBSCRIBE
News   Deals

Daiichi Sankyo Co Ltd. to Bid For Up to 20% of Ranbaxy Laboratories’s Zenotech Laboratories

January 20, 2009 | 
1 min read

TOKYO/MUMBAI, Jan 19 (Reuters) - Japanese drugmaker Daiichi Sankyo will make an open offer for up to 20 percent of Zenotech Laboratories, a unit of India’s Ranbaxy.

Mergers & acquisitions Asia
Daiichi Sankyo
MORE ON THIS TOPIC
Signage at Pfizer's world headquarters in New York City
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
March 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative background
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
 · 
2 min read
 · 
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
 · 
1 min read
 · 
Lori Ellis
Two human hands with a gesture of a handshake agreement and dollar banknotes with dollar signs on a colored background. Concept of business contract or agreement. Collage art
Editorial
The BioSpace Book Club Investigates the Biggest Deals of All Time
February 26, 2025
 · 
3 min read
 · 
Annalee Armstrong